Intratracheal Antitumor Necrosis Factor-α Antibody Attenuates Lung Tissue Damage Following Cardiopulmonary Bypass

Artificial Organs

Volumn 37, Issue 2, 2013, Pages 142-149

  Qi, Danni ^a   Gao, Ming Xin ^b   Yu, Yang ^b  

^a Tsinghua University   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Antitumor necrosis factor antibody; Apoptosis; Cardiopulmonary bypass; Lung injury; Lung protection

Indexed keywords

ANTIBODIES; CELL DEATH; GLYCOPROTEINS; MACROPHAGES; RNA; TISSUE;

ANTI-TUMORS; ANTITUMOR NECROSE FACTOR-Α ANTIBODY; CARDIOPULMONARY BYPASS; INTRATRACHEAL; LUNG INJURY; LUNG PROTECTION; LUNG TISSUE; NECROSIS FACTORS; PROTECTIVE EFFECTS; TNF Α;

BIOLOGICAL ORGANS;

LIQUID NITROGEN; MALONALDEHYDE; PHOSPHATE BUFFERED SALINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HEART ATRIUM; HEART LEFT ATRIUM; HEART RIGHT ATRIUM; HEART STRESS; LUNG INJURY; NEUTROPHIL COUNT; NICK END LABELING; NONHUMAN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORACOTOMY; WESTERN BLOTTING;

ORYCTOLAGUS CUNICULUS;

EID: 84873292239     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2012.01542.x     Document Type: Article

References (25)

1. Apostolakis E, Filos KS, Koletsis E, Dougenis D. Lung dysfunction following cardiopulmonary bypass. J Card Surg 2010;25:47-55.
2. Damgaard S, Nielsen CH, Andersen LW, Bendtzen K, Tvede M, Steinbruchel DA. Cell saver for on-pump coronary operations reduces systemic inflammatory markers: a randomized trial. Ann Thorac Surg 2010;89:1511-7.
3. Biancari F, Rimpilainen R. Meta-analysis of randomised trials comparing the effectiveness of miniaturised versus conventional cardiopulmonary bypass in adult cardiac surgery. Heart 2009;95:964-9.
4. Imura H, Caputo M, Lim K, etal. Pulmonary injury after cardiopulmonary bypass: beneficial effects of low-frequency mechanical ventilation. J Thorac Cardiovasc Surg 2009;137:1530-7.
5. Day JR, Taylor KM. The systemic inflammatory response syndrome and cardiopulmonary bypass. Int J Surg 2005;3:129-40.
6. Ho KM, Tan JA. Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis. Circulation 2009;119:1853-66.
7. Lucas R, Verin AD, Black SM, Catravas JD. Regulators of endothelial and epithelial barrier integrity and function in acute lung injury. Biochem Pharmacol 2009;77:1763-72.
8. den Hengst WA, Gielis JF, Lin JY, Van Schil PE, De Windt LJ, Moens AL. Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process. Am J Physiol Heart Circ Physiol 2010;299:H1283-99.
9. Imai Y, Kawano T, Iwamoto S, Nakagawa S, Takata M, Miyasaka K. Intratracheal anti-tumor necrosis factor-alpha antibody attenuates ventilator-induced lung injury in rabbits. J Appl Physiol 1999;87:510-5.
10. Chiang CH, Wu CP, Perng WC, Yan HC, Yu CP. Use of anti-(tumour necrosis factor-alpha) antibody or 3-deaza-adenosine as additives to promote protection by University of Wisconsin solution in ischaemia/reperfusion injury. Clin Sci (Lond) 2000;99:215-22.
11. Kotani N, Hashimoto H, Sessler DI, etal. Cardiopulmonary bypass produces greater pulmonary than systemic proinflammatory cytokines. Anesth Analg 2000;90:1039-45.
12. Yang Y, Ming Y, Qiuming X. Building a rabbit model of cardiopulmonary bypass. Chin J Clin Thorac Cardiovasc Surg 2003;10:151-2.
13. Stassano P, Di Tommaso L, Monaco M, etal. Myocardial revascularization by left ventricular assisted beating heart is associated with reduced systemic inflammatory response. Ann Thorac Surg 2009;87:46-52.
14. Andera L. Signaling activated by the death receptors of the TNFR family. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2009;153:173-80.
15. Fiorelli A, Morgillo F, Milione R, etal. Control of post-thoracotomy pain by transcutaneous electrical nerve stimulation: effect on serum cytokine levels, visual analogue scale, pulmonary function and medication. Eur J Cardiothorac Surg 2012;41:861-8.
16. Yamanouchi D, Kato K, Ryer EJ, Zhang F, Liu B. Protein kinase C delta mediates arterial injury responses through regulation of vascular smooth muscle cell apoptosis. Cardiovasc Res 2010;85:434-43.
17. Zimmer RJ, Lee MS. Transplant coronary artery disease. JACC Cardiovasc Interv 2010;3:367-77.
18. Vazquez-Jimenez JF, Liakopoulos OJ, Qing M, Messmer BJ, Seghaye MC. Tumor necrosis factor-alpha and troponin I release in porcine cardiac lymph and coronary sinus blood before and after cardiopulmonary bypass. Lymphology 2002;35:105-13.
19. Schroeder S, Borger N, Wrigge H, etal. A tumor necrosis factor gene polymorphism influences the inflammatory response after cardiac operation. Ann Thorac Surg 2003;75:534-7.
20. Decleva E, Dri P, Menegazzi R, Busetto S, Cramer R. Evidence that TNF-induced respiratory burst of adherent PMN is mediated by integrin alpha(L)beta(2). J Leukoc Biol 2002;72:718-26.
21. Becker BF, Chappell D, Bruegger D, Annecke T, Jacob M. Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovasc Res 2010;87:300-10.
22. Maianski NA, Roos D, Kuijpers TW. Tumor necrosis factor alpha induces a caspase-independent death pathway in human neutrophils. Blood 2003;101:1987-95.
23. Zhang C, Xu X, Potter BJ, etal. TNF-alpha contributes to endothelial dysfunction in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 2006;26:475-80.
24. Hill GE, Whitten CW, Landers DF. The influence of cardiopulmonary bypass on cytokines and cell-cell communication. J Cardiothorac Vasc Anesth 1997;11:367-75.
25. Klass O, Fischer UM, Antonyan A, etal. Pneumocyte apoptosis induction during cardiopulmonary bypass: effective prevention by radical scavenging using N-acetylcysteine. J Invest Surg 2007;20:349-56.